NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Diageo Hires "Drastic Dave" Lewis to Lead Major Turnaround

Spirits giant Diageo, facing high debt and tariffs, taps former Tesco CEO Dave Lewis (known for his successful Tesco turnaround) to revive growth and revitalize major brands like Johnnie Walker and Guinness.

Diageo Hires "Drastic Dave" Lewis to Lead Major Turnaround
Photo by Thimo van Leeuwen on Unsplash
Already have an account? Sign in.
Featured/ 11/10/2025 · 9:16 AM
DEO
/ Read more

Feed↓

Eli Lilly Signs $475M Deal with MeiraGTx for Vision-Restoring Gene Therapy
11/10/2025 · 10:56 AM

Eli Lilly Signs $475M Deal with MeiraGTx for Vision-Restoring Gene Therapy

Eli Lilly partners with MeiraGTx in a $475M deal for a breakthrough gene therapy, AAV-AIPL1, designed to restore vision in children born legally blind.

/ Subscriber only
MannKind Ends Phase 3 ICoN-1 Trial for Nebulized Clofazimine After Futility Review
11/10/2025 · 10:42 AM

MannKind Ends Phase 3 ICoN-1 Trial for Nebulized Clofazimine After Futility Review

MannKind Corporation discontinues its Phase 3 ICoN-1 trial for nebulized clofazimine (MNKD-101) in NTM lung disease after futility analysis shows no efficacy. The company will focus on developing its dry powder version, MNKD-102.

/ Subscriber only
Historic Breakthrough in GIST Treatment: Cogent’s Bezuclastinib Combination Poised to Become New Standard of Care
Featured/ 11/10/2025 · 10:00 AM

Historic Breakthrough in GIST Treatment: Cogent’s Bezuclastinib Combination Poised to Become New Standard of Care

Cogent Biosciences announced "transformative" success with their experimental drug, bezuclastinib, in combination with sunitinib, significantly delaying disease progression in patients battling advanced GIST (a form of stomach cancer).

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe